Morgan Stanley Call 675 LONN 20.0.../ DE000MG83XA5 /
| 2024-11-12 11:58:26 AM | Chg.-0.001 | Bid10:00:37 PM | Ask10:00:37 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 0.135EUR | -0.74% | - Bid Size: - |
- Ask Size: - |
LONZA N | 675.00 CHF | 2025-06-20 | Call |
GlobeNewswire
08-26
Simtra BioPharma Solutions Appoints Dr. Lidia Serina as Head of Development Sciences
GlobeNewswire
08-23
Galapagos announces FDA clearance of IND application for Phase 1/2 ATALANTA-1 study of CD19 CAR-T, G...
GlobeNewswire
08-08
Cabaletta Bio Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
08-06
Vaxcyte Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
06-14
Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at...
GlobeNewswire
05-30
Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively licens...
GlobeNewswire
05-15
Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ dec...
GlobeNewswire
05-08
Vaxcyte Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
04-04
Galapagos showcases innovative approach in hematological cancer care with clinical and translational...
GlobeNewswire
04-04
Acumen Pharmaceuticals Collaborates with Lonza to Advance Sabirnetug for the Treatment of Alzheimer’...
GlobeNewswire
02-27
Vaxcyte Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
GlobeNewswire
01-04
Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further exp...
GlobeNewswire
2023-12-19
Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufacture...
GlobeNewswire
2023-12-09
Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 an...
GlobeNewswire
2023-12-07
Galapagos to Host KOL Event on December 10, 2023, at 11:00 AM PST to discuss new data presented at A...
GlobeNewswire
2023-11-06
Vaxcyte Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire
2023-10-16
Vaxcyte and Lonza Expand Collaboration for Global Commercial Manufacturing of Broad-Spectrum Pneumoc...
GlobeNewswire
2023-10-02
Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer
GlobeNewswire
2023-09-20
Oxford Biomedica Plc - INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2023
